Testing a thin light-based needle probe during prostate biopsy
Tests a thin light-based needle probe that examines prostate tissue in men with prostate cancer.
Plain-language title generated from the registry record
Registry title: Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
Key facts
- Where
- Ann Arbor, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 80 years old?
Source: NCT05965180, who can take part
Where in United States
- University of Michigan Rogel Cancer CenterAnn Arbor, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Michigan Rogel Cancer Center
- Trial code
- NCT05965180
- Record updated
- 9 November 2026
- Original description
In this project, we will integrate the Photoacoustic (PA) technology into a prostate biopsy procedure through a fine needle probe. The needle probe will be in the shape of a biopsy needle and compatible with the needle insertion mechanism in the transrectal ultrasound (TRUS) probe. When inserted into the prostate, the fine needle PA probe will assess the histological information in its surrounding tissue without any tissue extraction. The needle probe has been tested in prostate tissue samples and whole human prostates ex vivo.Read full original descriptionShow less
Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
In this project, we will integrate the Photoacoustic (PA) technology into a prostate biopsy procedure through a fine needle probe. The needle probe will be in the shape of a biopsy needle and compatible with the needle insertion mechanism in the transrectal ultrasound (TRUS) probe. When inserted into the prostate, the fine needle PA probe will assess the histological information in its surrounding tissue without any tissue extraction. The needle probe has been tested in prostate tissue samples and whole human prostates ex vivo.
Inclusion: 1) Planned prostate biopsy as part of routine clinical care; 2) > 40 and <80 years old.
Exclusion: 2) Patients taking anticoagulants, no matter doses or washout time; 1) Known history of bleeding disorders or; 3) Known allergy to silicone material; 4) Unable to provide informed consent; 5) Either the surgeon or the patient do not think the patient will not be able to complete all parts of the study, the patient will be excluded; 6) Involved in other investigational studies.